AUG 07, 2020 4:03 PM PDT

Immune-Related Genes as Prognostic Biomarkers

WRITTEN BY: Jasper Cantrell

Cancer is one of the most persistent and hardy diseases. Cancers often develop the ability to suppress the immune system. A tumor can interact with its immediate environment, and “turn off” certain immune cells. These immune cells, which usually survey the body for problems, become blind to the tumor and cannot target it for destruction.

Melanoma is a deadly form of cancer with a poor five-year prognosis. It has several biomarkers useful for its general diagnosis, but a team from Central South University in China found them to have poor prognostic abilities. Melanoma has a strong link to the immune system, so they hypothesized that immune-related genes could be biomarker candidates for melanoma.

The study would utilize two databases: the Gene Expression Omnibus, and The Cancer Genome Atlas. Both are public genetic databases that contain expression data from patients with and without cancer. Using these data, they identified genes that had different expression levels in melanoma versus healthy skin tissue. They then cross-referenced the hits with known immune-related genes to identify 81 biomarker candidates. Most of these candidates turned out to be involved in cytokine and chemokine pathways, which are critical signaling pathways involved in the immune response.

Further analysis of the 81 candidates showed that two, in particular, CCL8 and DEFB1, had real potential as biomarkers. They developed a basic formula to generate an immune-related gene (IRG) score that could separate patients into either a high or a low-risk group. The high-risk group was characterized by decreased CCL8 levels and increased DEFB1 levels. With the IRG score, alongside age and stage of cancer, the team could reasonably predict the 3 and 5-year overall survival rates using data from the databases.

This study represents an attempt to identify immune-related biomarkers for the prognosis of melanoma. The accuracy of the overall test was reasonable and may present a useful tool for doctors should it be validated. The team made an interesting observation that the high-risk group seemed to respond better to anti-PD-1 therapy, a common chemotherapy for many cancers, than the low-risk group. They noted the group for that test was small, so it may not be a real finding.

Biomarkers are a challenge to study, considering the incredibly diverse cancer expression profiles out there. The team concludes, “we have constructed a predictive model which combined immune-related genes with clinical characteristics for the first time, to estimate melanoma patient survivals and therefore help with decision making in the treatment.”

Sources: Nature Scientific Reports, European Society for Medical Oncology

About the Author
Bachelors of the Sciences
Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
AUG 02, 2022
Cell & Molecular Biology
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
AUG 02, 2022
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
Introduction Centrifugation and filtration have been widely accepted as techniques required for clarifying complex cell ...
AUG 09, 2022
Immunology
New Small Molecule May Improve Immunotherapy for a Variety of Cancers
AUG 09, 2022
New Small Molecule May Improve Immunotherapy for a Variety of Cancers
Scientists have been trying to stimulate the immune system to fight cancer for decades, and recent years have brought ma ...
AUG 12, 2022
Immunology
Study Suggests that Terminally Exhausted T cells can be Rejuvenated
AUG 12, 2022
Study Suggests that Terminally Exhausted T cells can be Rejuvenated
Our immune cells can target cancer, but T cells can become worn out and exhausted  during lengthy battles, and they ...
AUG 21, 2022
Cancer
The Legacy of Lady Mary Wortley Montagu
AUG 21, 2022
The Legacy of Lady Mary Wortley Montagu
Today, August 21, marks the 260th anniversary of the passing of a pioneer in the medical field.  In 1762, Lady Mary ...
SEP 19, 2022
Cancer
Smoking Cessation Impacted by the COVID Pandemic
SEP 19, 2022
Smoking Cessation Impacted by the COVID Pandemic
Smoking remains a major risk factor for several types of cancer.  While the association between lung cancer and smo ...
OCT 12, 2022
Plants & Animals
Mediterranean Diet Improves Immunotherapy Response in Advanced Melanoma Patients
OCT 12, 2022
Mediterranean Diet Improves Immunotherapy Response in Advanced Melanoma Patients
The Mediterranean diet has been popularized in recent years for its wide-ranging health benefits. Among the many health ...
Loading Comments...